Patent Office Program To Speed Computer Tech
coondoggie writes "Looking to address critics, the US Patent and Trademark Office this week is starting a program to speed up and improve the review of computer hardware and software technologies. The agency is set to launch a peer-review pilot project that will give technical experts in computer technology, for the first time, the opportunity to submit technical reports relevant to the claims of a published patent application before an examiner reviews it. The idea is to get as much knowledge about a particular claim in front of an examiner as quickly as possible so they can make a decision faster, the agency said. IBM, Microsoft, General Electric, Hewlett-Packard, CA, and Red Hat have already agreed to review some software patent applications for the one-year community review project. Intel, Sun, Oracle, Yahoo, and others are also part of the project. The pilot is a joint initiative with the Community Patent Review Project, organized by the New York Law School's Institute for Information and Policy.
I just wish they would make it retroactive to all the other patents currently awarded.
Compeditors have more to gain from a patent portfolio+cross licensing agreement then they do from invalidated patents. Unless we have public review or honest people reviewing this won't work.
Inventions have long since reached their limit, and I see no hope for further development.-- Frontinus, 1st cent. AD
Realize that software is not a patentable innovation.
The use of patents has seriously gotten ridiculous and has made me lose faith in the US Patent Office.
Skiffy is Spiffy, but Ort is tort.
How long until we start seeing reports of rejected patents, that are later submitted by the big companies involved in the peer review?
"from the foxes-guarding-the-henhouse dept."
That's basically what this is.
-----
"You spilled my egg... I needed that egg."
Unless the pharmaceutical companies were sure they could recoup these billions of dollars, there would be no incentive to invent any new drugs.
I don't even like your Patents don't really serve the public interest here either, because we don't really need pharmaceutical companies in the first place. One sign that our kleptocracy has completely warped our thinking is this strange assumption everyone makes: if drug companies don't make lots of profits inventing new drugs, nobody will have any incentive to invent drugs.
We really don't need pharmaceutical companies. The public wants access to a wide range of cheap effective medicines. So we have a natural incentive to invent new drugs because we keep getting sick and dying. There are plenty of ways to solve the problem. A straightforward one would be to create public drug discovery laboratories, fund university labs, and pay for scientists to find the drugs. That's a "tax and spend" solution. We decided on a solution where we replace our natural incentive for better drugs with Pfizer's incentive to get rich selling them to us.
That works to the extent your desire for better drugs remains compatible with the perogatives of a for-profit corporation. Sometimes it isn't. A company makes more money by developing treatments as opposed to cures. It saves money by making copycats of drugs already shown to be profitable, like penis pills. They concentrate their efforts on diseases with the widest markets, and don't do much research into rare diseases. And of course they spend a lot of time looking into what they should do if they want to pull even more money out of your pocket. My wife and I are still young but we each have our own chronic neurological problem. Just the copays on these prescriptions are exploding. Ours are running about $150-200/month. And the trail of patents and monopoly rights left behind by this process is undesirable in and of itself, even if getting them did provide the company's incentive. For one thing, the patents rise into the atmosphere and do not expire for years and years. The air becomes clogged with patents and they accumulate into a dark cloud that casts shadows and disincentives upon drug research below- no matter who is doing it. So our current path isn't sustainable.
There is plenty of incentive to invest in new drugs as long as people are sick and dying. Even if a private company isn't interested, there are enough people who do that research, and sufficient public interest in getting it done, to ensure that it will get done, even if nobody is getting rich running commercials for me-too penis pills. Only patents could screw it up.